Quarterly Actuals vs Estimates

Avalon Pharma Q4 2025 earnings: Analyst forecasts

Value Traded4,807,766,694
Open11,146.96
Prev. Close11,155.45
High11,147.04
Low10,929.79
YTD 4.35 %
Transactions 429,270
Volume 254,827,055
Market Cap (Million) 3,153,013.38
Company Price Change Price Earnings
ALBILAD GOLD ETF 26.24 2.74 % -
MUSHARAKA REIT 4.34 2.12 % NEG
SHAKER 17.20 1.18 % 14.25
ALBILAD US TECH ETF 22.13 0.91 % -
SIECO 2.51 0.80 % NEG
Company Price Change Price Earnings
ABO MOATI 39.00 (9.30 %) 34.59
CARE 128.80 (8.98 %) 18.14
NCLE 116.50 (6.35 %) 40.41
NASEEJ 23.91 (6.24 %) NEG
ALAKARIA 13.95 (6.00 %) 11.45
Company Last Price Volume
AMERICANA 2.07 52,690,016
SIECO 2.51 8,920,176
SAUDI ARAMCO 25.70 8,432,396
CHEMICAL 7.98 8,311,280
SAUDI KAYAN 5.37 8,019,946
Company Last Price Turnover
ALRAJHI 102.00 396,562,612
SNB 41.90 251,332,746
SAUDI ARAMCO 25.70 216,192,445
CARE 128.80 185,357,074
STC 43.00 173,080,512

Analyst Recommendations

Date Company Research Firm Rating
19/02/2026 SAUDI ARAMCO AlJazira Capital Overweight
19/02/2026 LUBEREF SNB Overweight
18/02/2026 SNB United Securities Company Buy
18/02/2026 BSF Sico Buy
17/02/2026 ALRAJHI United Securities Company Hold

Major Shareholder Changes

Company / Shareholder Current Holding Prev. Holding Change Note
Saudi Industrial Export Co.
Adel abdallah nasser alaadjlan
5.40% 5.36% 0.04%
Al-Jouf Agricultural Development Co.
Riyad M. A. Al Humaidan
20.50% 20.47% 0.03%
Al-Jouf Agricultural Development Co.
Almunajem Foods Co.
6.67% 6.64% 0.03%
The National Company for Glass Industries
Riyad M. A. Al Humaidan
19.28% 19.26% 0.02%

Calendar

Company Event
BHGE Reports